Drs. Edelman and Pettus discuss the novel type 2 medicine Mounjaro, a combination GLP-1/GIP that helps lower A1c and promote weight loss.
read more →
One of the most common challenges for people with diabetes is trying to prevent blood sugars from shooting up after meals. Drs. E and P have been managing spikes for over 75 years between the two of ’em, and they offer clear-cut suggestions on how to keep post-meal highs at bay.
read more →
The FDA recently approved a novel medication called Mounjaro. See how this once-weekly therapy works to significantly lower A1c and promote weight loss in people with type 2 diabetes.
read more →
Medicare recently launched a new program called the Medicare Part D Senior Savings Model Program to test the impact of giving Medicare beneficiaries 65 and older an increased choice of Part D plans with no deductible and a max copay of $35 per month for insulin and fixed-ratio combination GLP-1 RAs Soliqua and Xultophy.
read more →
The FDA recently approved Wegovy, the first and only once-weekly injection for chronic weight management in adults.
read more →